###begin article-title 0
RNA-editing-mediated exon evolution
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
A primate-specific exon is found to be dependent on RNA editing for its exonization.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 147 150 147 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 310 315 <span type="species:ncbi:9606">human</span>
Alu retroelements are specific to primates and abundant in the human genome. Through mutations that create functional splice sites within intronic Alus, these elements can become new exons in a process denoted exonization. It was recently shown that Alu elements are also heavily changed by RNA editing in the human genome.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 94 97 94 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 432 435 432 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 22 27 <span type="species:ncbi:9606">human</span>
Here we show that the human nuclear prelamin A recognition factor contains a primate-specific Alu-exon that exclusively depends on RNA editing for its exonization. We demonstrate that RNA editing regulates the exonization in a tissue-dependent manner, through both the creation of a functional AG 3' splice site, and alteration of functional exonic splicing enhancers within the exon. Furthermore, a premature stop codon within the Alu-exon is eliminated by an exceptionally efficient RNA editing event. The sequence surrounding this editing site is important not only for editing of that site but also for editing in other neighboring sites as well.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 137 142 <span type="species:ncbi:9606">human</span>
Our results show that the abundant RNA editing of Alu sequences can be recruited as a mechanism supporting the birth of new exons in the human genome.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 26 31 <span type="species:ncbi:9606">human</span>
Analysis of the sequenced human genome has revealed that it contains about 200,000 exons [1]. However, the exon content in mammalian genes is far from static. Rather, it is constantly changing through a dynamic evolutionary process in which exons are newly created and deleted. New exons can arise from gene duplication [2] and exon duplication [3], but perhaps the most intriguing process by which exons can be born is exonization by exaptation, where genomic sequences that did not originally function as exons are adopted into exonic sequences [4].
###end p 10
###begin p 11
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 529 530 529 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 533 536 533 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 763 764 763 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 765 766 765 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 775 779 775 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 128 133 <span type="species:ncbi:9606">human</span>
###xml 249 254 <span type="species:ncbi:9606">human</span>
###xml 824 829 <span type="species:ncbi:9606">human</span>
We have recently shown that Alu elements use this exonization mechanism to give rise to hundreds of novel internal exons in the human genome [5]. Alu elements are unique primate-specific retrotransposons that occur in over one million copies in the human genome [2,6,7]. Their 300 bases-long consensus sequence contains motifs that resemble 5' and 3' potential splice sites (5' ss and 3' ss, respectively). Random mutations can turn these motifs into functional splice sites that can be recognized by the splicing machinery [5,8,9]. Alu-derived internal exons are almost always alternatively spliced, allowing the original isoform to coexist with the new one and preventing the deleterious effects of introducing a new protein at the expense of the original one [5,8]. Thus, Alu elements can increase the coding capacity of human genes while maintaining the original protein repertoire.
###end p 11
###begin p 12
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 791 792 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 793 795 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 887 891 887 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 926 930 926 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 964 967 964 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 1075 1078 1075 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 1187 1190 1187 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 1352 1354 1352 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1355 1357 1355 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1358 1360 1358 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 704 709 <span type="species:ncbi:9606">human</span>
###xml 750 755 <span type="species:ncbi:10090">mouse</span>
###xml 757 760 <span type="species:ncbi:10116">rat</span>
###xml 762 769 <span type="species:ncbi:9031">chicken</span>
###xml 834 839 <span type="species:ncbi:9606">human</span>
###xml 946 951 <span type="species:ncbi:9606">human</span>
Recently, Alus were reported to contribute to human transcriptome diversity by an additional mechanism, involving adenosine-to-inosine (A-to-I) RNA editing. A-to-I RNA editing refers to the deamination of selected adenosine residues, altering the nucleotide sequence of RNA transcripts from that encoded by genomic DNA. It is catalyzed by enzymes from the ADAR (adenosine deaminase acting on RNA) family. Editing targets are typically located within double stranded RNA (dsRNA), which is recognized by the ADAR enzymes [10]. RNA editing can cause non-synonymous codon changes when occurring inside the coding sequence or occur in the non-coding parts of the pre-RNA molecule. It was lately reported that human transcripts contain excess editing over mouse, rat, chicken and fly transcripts [5,11,12]. The majority of editing sites in human (approximately 96%) were found to occur within Alu sequences. Due to the abundance of Alu elements in the human genome, two Alus in opposite orientation are frequently found near each other. When transcribed in the pre-mRNA, these two Alus can presumably fold to create a dsRNA; this substrate is recognized and edited by the ADAR enzymes. Edited Alus typically do not contribute to the protein repertoire, but rather reside in non-coding parts of the pre-RNA molecule - untranslated regions (UTRs) and introns [11,13-18].
###end p 12
###begin p 13
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 215 218 215 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 374 380 374 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAR2 </italic>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 594 598 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 698 701 698 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 1232 1235 1232 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 1349 1354 <span type="species:ncbi:9606">human</span>
The observation that Alu elements are both extensively edited and can give rise to novel alternatively spliced exons in primate genomes raises the question of whether RNA editing can be involved in the birth of new Alu-exons. RNA editing was previously shown to regulate alternative splicing by creating a splice site [19]. The most studied event is the auto-editing of the ADAR2 gene, in which intronic AA dinucleotide turns into a functional AG 3' ss following RNA editing [19]. Indeed, it was recently suggested that such editing events may create functional splice sites in silent intronic Alu elements, thus promoting their exonization [13]. In this study we detected a novel primate-specific Alu-exon that exclusively depends on RNA editing for its exonization. We show that RNA editing regulates the exonization in a tissue-dependent manner, both through creation of a functional AG 3' ss, elimination of a premature stop codon, and regulation of the inclusion/skipping level through alteration of exonic splicing enhancers and silencers within the exon. We also demonstrated that the sequence around an editing site is important not only for the editing in that site but also editing in neighboring sites located along this Alu-exon. Our results show that RNA editing can be recruited as a mechanism supporting the birth of new exons in the human genome.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
RNA editing enables exonization of a nuclear prelamin A recognition factor Alu-exon
###end title 15
###begin p 16
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 344 347 344 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 583 593 583 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bona fide </italic>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 731 734 731 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 944 945 944 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 221 226 <span type="species:ncbi:9606">human</span>
###xml 270 275 <span type="species:ncbi:9606">human</span>
To check the possibility that Alu-derived exons were fixed into protein-coding genes through an RNA-editing-mediated process, we first used expressed sequence tags (ESTs) and cDNAs from GenBank version 136 aligned to the human genome (version hg16) to identify internal human exons that contain Alu elements, as described in [5]. We looked for Alu-containing exons flanked by either AA at the 3' ss or AT at the 5'ss. These non-canonical splice sites will normally not be selected by the splicing machinery; however, each of these splice sites is theoretically capable of becoming a bona fide splice site through A-to-I RNA editing, because inosine is recognized by the splicing apparatus as a guanosine [19]. We demanded that the Alu-exon will be supported by more than one EST/cDNA, and that it neither induced frame-shift nor contained a stop codon, as these parameters were shown to be indicative of functional alternatively spliced exons [5].
###end p 16
###begin p 17
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 337 340 337 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
We were able to detect one such Alu-derived exon, having an AA 3' ss, that conformed to the above conditions (Figure 1). This exon is the eighth exon in the nuclear prelamin A recognition factor (NARF), a protein that interacts with the carboxyl-terminal tail of prelamin A and localizes to the nuclear lamina [20]. As with all internal Alu-containing exons described to date, it is alternatively spliced, and exon-inclusion is supported by seven cDNAs, including the full-length cDNA (GenBank:; UCSC March 2006 version). The exon inserts 46 in-frame additional amino acids into the coding sequence of NARF.
###end p 17
###begin p 18
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 495 498 495 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 514 518 514 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 570 573 570 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 601 604 601 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 814 817 814 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 211 216 <span type="species:ncbi:9606">human</span>
A-to-I RNA editing takes place in the context of dsRNA, to which the ADAR proteins bind through a dsRNA-binding domain (reviewed in [21,22]). It was therefore shown that, for the vast majority of edited Alus in human exons, there is a nearby (up to 2,000 base-pairs apart) intronic Alu counterpart in the opposite orientation, which presumably serves as the template for dsRNA formation [13,14]. Indeed, we were able to find an oppositely oriented Alu sequence 25 bases upstream of the exonized Alu. The antisense Alu has 81% identity when aligned to the exon-producing Alu, suggesting that these two Alus might form a stable intramolecular dsRNA formation following transcription (Figure 1b). This, in addition to the non-canonical AA splice site, implies that RNA editing participates in the exonization of that Alu.
###end p 18
###begin p 19
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 149 152 149 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 323 326 321 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 340 342 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 626 629 624 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 251 256 <span type="species:ncbi:9606">human</span>
###xml 810 815 <span type="species:ncbi:9606">human</span>
Editing within Alu elements frequently occurs in more than one position, due to the long RNA duplex usually formed by two oppositely oriented nearby Alus [11,13-15,18,23]. Indeed, by searching for A-->G discrepancies in the alignments of cDNAs to the human genome we detected five additional potential editing sites in the Alu-exon (Figure 1b, E1-E5). The first of these, found in position 19 of the exon, is of particular interest, because it has the potential to change a TAG codon (termination of translation) to a TGG codon (coding for tryptophane). In the absence of RNA editing in the E1 position, the insertion of this Alu-exon would have caused a premature termination. It is important to note that the editing in the exonic E1-E5 sites is directly recognizable from the ESTs or cDNAs in comparison to human genomic DNA, whereas editing in the potential 3'ss is postulated based only on the genomic sequence.
###end p 19
###begin title 20
###xml 38 43 <span type="species:ncbi:9606">human</span>
Different levels of exonization among human tissues
###end title 20
###begin p 21
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 422 426 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 861 862 861 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 866 868 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1064 1068 1064 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 1319 1321 1319 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 1406 1408 1406 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 197 202 <span type="species:ncbi:9606">human</span>
###xml 316 321 <span type="species:ncbi:9606">human</span>
###xml 356 361 <span type="species:ncbi:9606">human</span>
###xml 457 462 <span type="species:ncbi:9606">human</span>
###xml 1221 1226 <span type="species:ncbi:9606">human</span>
To check whether this putative Alu-exon is indeed spliced into the mature mRNA of NARF, we tested the existence of the exon-inclusion and exon-skipping forms in endogenous mRNA from various normal human tissues and cell-lines. As shown in Figure 2, the inclusion form was detected in all cDNAs generated from normal human tissues as well as from different human cell lines. This indicates that the exonization of the NARF Alu is evolutionarily fixed in the human transcriptome. Moreover, exon inclusion levels in different tissues followed expected levels of RNA editing in those tissues. For example, brain, kidney and spleen showed the highest levels of exon inclusion while skeletal muscle showed the lowest levels of exon inclusion (Figure 2a; Additional data file 1). These results are in line with genome wide analysis of edited RNA in different tissues [5,11,13,15] and to the amount of inosine detected in RNA in various tissues [24]. The above results further suggest that RNA editing is involved in the regulation of alternative splicing of the exonized Alu in the gene encoding NARF. Interestingly, we note high levels of exon inclusion in MCF7 and 293T cell-lines, but not in HeLa, SKOV3 and MDAH cell-lines (human cancer cell lines originated from breast, kidney, cervix and ovaries, respectively) (Figure 2a), although the global editing level in cell-lines is expected to be relatively low [11]. This demonstrates that the amplitude of editing level in various cell line types is of a variable nature.
###end p 21
###begin p 22
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 887 889 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
We sequenced all of the exon inclusion PCR products and analyzed the editing frequencies at the five editing sites (named E1-E5, Figure 1b) using the Discovery Studio (DS) Gene 1.5 program (Accelrys Inc., San Diego, CA, USA). Importantly, the first exonic editing site, E1 (at position 19 of the exon), was edited at nearly 100% efficiency in all tested tissues and cell lines, whereas the editing levels of the other sites varied (E2 being edited in an average of 53.6% of RNAs, E3 in an average of 26.1%, E4 in an average of 7.9% and E5 in an average of 37.5%) (Figure 2b). Notably, editing sites E1, E3 and E5 are mistakenly annotated as single nucleotide polymorphisms (SNPs) in dbSNP [25] (rs17855348, rs17849311 and rs17855349, respectively) based on the variance in cDNA data. Many similar examples of RNA editing sites erroneously deposited in dbSNP have been recently reported [26].
###end p 22
###begin p 23
###xml 249 252 249 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1050 1053 1050 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 1112 1115 1112 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 831 836 <span type="species:ncbi:9606">human</span>
###xml 1142 1147 <span type="species:ncbi:9606">human</span>
Usually, editing efficiency is much lower than 100% per site, depending on the expression levels of the ADAR enzymes in the given tissue, the secondary structure of the substrate, or the surrounding sequence. As shown above, position E1 in the NARF Alu-exon is edited in nearly all RNA molecules containing this exon. Inactivation of the nonsense-mediated mRNA decay (NMD) by adding puromycine (see Materials and methods) to 293T cell line did not affect the >97% editing efficiency in site E1 (data not shown). This indicates that the high level of editing in site E1 is not due to elimination of unedited, stop-codon containing mRNAs, but rather is indicative of a high efficiency of editing in that site. Apart from the Q/R site of gluR-B [27], which is restricted to brain, this is the highest editing efficiency documented in human, though it has a much broader tissue expression spectrum. This result suggests that additional regulatory mechanisms have evolved to ensure that the stop codon is edited to a Trp codon in all mRNAs containing the Alu-exon. It further implies that the exonization of the NARF Alu-exon is functional in the human transcriptome.
###end p 23
###begin title 24
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
Alu-Alu dsRNA directs exonization
###end title 24
###begin p 25
###xml 271 274 271 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 629 632 629 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 147 152 <span type="species:ncbi:9606">human</span>
To substantiate the possibility that exon 8 in NARF was exonized through an RNA-editing-mediated process, we constructed a minigene containing the human genomic sequence of the gene encoding NARF from exon 7 to 9, including the two introns in between and the alternative Alu-exon. Following transfection of this minigene into 293T cells, total RNA was collected, and the splicing pattern of the NARF minigene was examined by RT-PCR analysis using primers specific to the plasmid cDNA and not the endogenous one (see Materials and methods). We then tested the effect of serial intronic and exonic mutations on the splicing of the Alu-exon (Figure 3a).
###end p 25
###begin p 26
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 204 208 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 241 245 241 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 348 351 348 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 542 546 542 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 601 604 601 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 707 711 705 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 719 721 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 1200 1202 1192 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 1327 1331 1317 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 1379 1383 1369 1373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 1515 1518 1505 1508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 1645 1648 1635 1638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
When the wild-type minigene was transfected into 293T cells, 23% of the mature mRNAs derived from this minigene represented the exon-inclusion form (Figure 3b, lane 1). However, deletion of the antisense Alu element upstream of the exonized Alu resulted in total abrogation of exon inclusion (Figure 3b, lane 2), indicating that these two adjacent Alus probably pair to create the dsRNA that is required for RNA editing. Without this dsRNA, editing does not occur, and functional AG in the 3'ss cannot be created. The effect of the antisense Alu deletion was reversed when the AA splice site near the Alu-exon was mutated to AG, indicating that a single AA-->AG change is sufficient for exonization of this Alu (Figure 3b, lane 3). Interestingly, the AA-->AG mutation increased exon-inclusion two-fold over the wild type, suggesting that, in 293T cells, about one-third of the AA pairs in the 3'ss are edited into a functional AG 3' ss. Also, a single AA-->AT mutation at the 3'ss, created on the wild-type plasmid, resulted in full exon skipping, indicating the importance of editing at that site for exonization. Whereas, a single AA-->AG mutation resulted in approximately 30% exonization (Figure 3b, lanes 4 and 5). The higher level of exonization after a single AA-->AG mutation at the 3'ss without and with the antisense Alu presumably suggests that although the antisense Alu is essential for exonization, it also reduces the level of maximum exonization by interfering with spliceosome accessibility to the Alu-exon due to dsRNA formation (compare lanes 3 and 5). Combined together, these results demonstrate that the exonization of the Alu-exon 8 in NARF is mediated by RNA editing, and that this mechanism also controls the level of inclusion of this exon in different tissues.
###end p 26
###begin title 27
Editing in one site affects the level of editing in other sites and the surrounding sequence and the opposite nucleotide are important for editing
###end title 27
###begin p 28
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 251 255 251 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b,c</xref>
###xml 570 574 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 765 769 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b,c</xref>
To test the possibility that specific sequences within the Alu-Alu duplex are involved in the regulation of high efficiency editing at the E1 site, we mutated the two nucleotides surrounding the edited site, as well as the nucleotide in the antisense Alu that is postulated to be opposite to the edited nucleotide within the dsRNA (see Figure 4a for the mutated nucleotides). All these mutations substantially reduced the editing in the E1 site (Figure 4b,c), indicating the importance of the surrounding sequence and the postulated opposite nucleotide in the antisense Alu for editing at that site. Moreover, mutations M2 and M3 also resulted in a significant reduction of RNA editing in the other exonic sites - the most significant effect was on site E2 (Figure 4b,c). This might suggest that the edited position is part of a sequence motif that directs high efficiency RNA editing at the other sites as well.
###end p 28
###begin p 29
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 499 502 499 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 515 516 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 675 676 675 676 <underline xmlns:xlink="http://www.w3.org/1999/xlink">A</underline>
###xml 711 712 711 712 <underline xmlns:xlink="http://www.w3.org/1999/xlink">G</underline>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1079 1081 1079 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1082 1084 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1395 1396 1395 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Our results indicate that RNA editing not only enables the exonization of the NARF Alu-exon, but also regulates its inclusion levels in different tissues (Figure 2). This regulation is probably attributed to the efficiency by which the AA splice site is edited to AG. However, another possible mechanism by which RNA editing can control exon inclusion levels is by altering exonic splicing enhancers and silencers (ESEs and ESSs, also denoted exonic splicing regulatory sequences (ESRs)) within the Alu-exon (Table 1). Indeed, editing of the first exonic site (E1) is predicted to eliminate a putative ESR ([28]; see also ESRsearch [29]. It also exchanges a putative ESS (GGTAGT) with another putative ESS (TGGTGG), as predicted by RescueESE [30]. In addition, the second exonic edited site (E2; position 30 in the exon) is part of four putative SR binding sites (Serine/Argenine-rich domain); editing reduces the score of the SF2/ASF binding site, eliminates a putative SRp40 ESR, creates a SRp55 ESR and also eliminates a putative ESR (as predicted by ESEfinder and ESRsearch [28,31]). In site E3, editing creates a putative high-scoring recognition site for the splicing factor SC35, as predicted by ESEfinder. Editing of E4 creates a putative recognition site for the splicing factor SC35, as predicted by ESEfinder. Editing of site E5 is predicted to have an effect on multiple ESRs (Table 1).
###end p 29
###begin title 30
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
RNA editing regulates the inclusion level of the NARF Alu-exon
###end title 30
###begin p 31
###xml 84 87 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 389 393 389 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 580 581 580 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 782 783 782 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1083 1085 1083 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
To test the possibility that RNA editing regulates the inclusion levels of the NARF Alu-exon by altering ESRs within the exon, we serially mutated each of the exonic edited sites from A-to-G, simulating 100% editing efficiency. To examine the effect of the exonic sites only we used a minigene in which an A-to-G mutation mimics 100% editing in the 3'ss, and we also deleted the antisense Alu that affects editing of the exonic sites. As shown in Figure 5, an A-to-G mutation in E1 and E3, but not in E2 and E5, resulted in a significant increase in exon inclusion levels (Figure 5, compare lanes 2 and 4 with lanes 3 and 6). However, editing in position E4 significantly reduced the inclusion level, suggesting the creation of a putative SC35 site that functions as an ESS (Figure 5, lane 5). These results indicate that editing of three out of the five exonic edited sites affects alternative splicing levels. However, it is unlikely that alternative splicing is regulated through editing in the E1 site, because it is uniformly edited at high levels in all tissues tested (Figure 2b).
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 383 388 383 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 442 446 442 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 489 492 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
We have demonstrated that the NARF Alu-exon 8 is exonized via RNA editing and that RNA editing is also involved in its tissue-dependent regulation. Previously, RNA editing was implicated in both anti-viral protection and transcript diversity regulation; we now show that editing can also support evolutionary processes such as the birth of new exons. In a recent study, Athanasiadis et al. [13] presented computational predictions of several Alu exonization events (not including the NARF Alu-exon) that were hypothesized to be regulated by RNA editing; our results provide exemplary confirmation of the validity of these predictions.
###end p 33
###begin p 34
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 189 192 189 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 428 431 428 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 805 809 805 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 1183 1184 1183 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
It has been shown that a few hundred Alu elements become exonized through single base-pair mutations that create functional splice sites within their sequences. Yet in the case of the NARF Alu-exon, exonization strictly depends on RNA editing. This situation provides a simple, yet powerful, way to regulate the levels of exon inclusion in a tissue/developmental stage-specific manner. Since editing levels control the level of Alu-exon inclusion, exon inclusion rates would follow the varying editing levels in different tissues (Figure 2). Usually, many regulatory sequence elements are needed to regulate alternative splicing in a tissue-specific manner. These sequence elements presumably can extend up to 150 bases from each side of the regulated exon [32]. It is unlikely that a recently retroposed Alu element will carry all needed splicing regulatory elements; however, the RNA-editing-dependent exonization does not rely on such extensive sequence elements, and mainly depends on the expression level of the editing enzymes (ADARs) in the specific tissue. Moreover, we show that editing of two out of the five exonic edited sites affects alternative splicing levels (Figure 5). This provides an additional layer of regulation of alternative splicing through RNA editing.
###end p 34
###begin p 35
###xml 295 298 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 305 308 305 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 462 465 462 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 518 521 518 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 580 583 580 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 669 672 669 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 794 797 794 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 981 984 981 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 61 75 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 88 98 <span type="species:ncbi:9598">chimpanzee</span>
###xml 250 255 <span type="species:ncbi:9606">human</span>
###xml 260 270 <span type="species:ncbi:9598">chimpanzee</span>
###xml 388 393 <span type="species:ncbi:9606">human</span>
###xml 398 408 <span type="species:ncbi:9598">chimpanzee</span>
###xml 421 435 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 550 555 <span type="species:ncbi:9606">human</span>
###xml 720 725 <span type="species:ncbi:9606">human</span>
###xml 807 821 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 893 898 <span type="species:ncbi:9606">human</span>
###xml 994 1008 <span type="species:ncbi:9544">rhesus macaque</span>
Interestingly, the E1 as well as the E5 editing sites in the rhesus macaque (but not in chimpanzee) genome encode 'G', thus presenting only the edited version of the gene in those sites. However, there are differences between the genomic sequence of human and chimpanzee and that of rhesus. The Alu-exon (AluSx) and the sequence upstream and downstream of it are highly conserved between human and chimpanzee. But in the rhesus macaque there was an insertion of AluY (in the sense orientation) immediately upstream of AluSx (the one that exonized in human), leading the antisense AluSg (the one that forms the dsRNA) to be located 344 nucleotides upstream of the sense AluSx (and not 25 nucleotides upstream as it is in human). In addition, there was an insertion of 8 nucleotides in the sense AluSx in the rhesus macaque as well as a deletion of 44 nucleotides that includes the site used in human as 3'ss (Additional data file 2). These differences raise the question of whether AluSx in the rhesus macaque exonized at all.
###end p 35
###begin p 36
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 113 122 113 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bona fide</italic>
###xml 198 202 198 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 284 285 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 347 353 347 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAR2 </italic>
###xml 371 374 371 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 429 432 429 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 153 158 <span type="species:ncbi:9606">human</span>
The observed exonization of the NARF Alu-exon in all tested tissues and cell lines indicates that this exon is a bona fide, fixed functional exon in the human genome that originated from an exapted Alu (that is, an Alu that adopted a new function that was not its original function) [4]. An additional example for such exaptation is exon 8 of the ADAR2 gene, which is an Alu-exon of 120 nucleotides (inserts 40 amino acids). The Alu-exon inclusion isoform does not change the specificity of ADAR2 activity compared to the original isoform (exon skipping) but rather changes the rate of the enzymatic activity [33].
###end p 36
###begin p 37
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 961 964 961 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 1136 1139 1136 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 1381 1384 1381 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 1171 1176 <span type="species:ncbi:9606">human</span>
Few mammalian ADAR substrates in which editing causes amino acid substitutions have been found so far; the first (and most studied ones) encode receptors that are all expressed in the central nervous system, including subunits of the glutamate receptor superfamily [27], the serotonin 5-HT2C-receptor [34] and the potassium channel KCNA1 [35]. In all these examples, the amino acid substitutions due to editing have been shown to have a major impact on protein properties, and altered editing patterns in the genes encoding them have been found to be associated with several diseases, such as epilepsy [36], depression [37], ALS (Amyotrophic Lateral Sclerosis) [38], and malignant gliomas [39]. Lately, additional evolutionarily conserved RNA editing sites that lead to a codon exchange have been discovered in another four genes [15,40] - the functional importance of these sites was deduced by their extreme evolutionary conservation. The editing in the NARF Alu-exon is the only experimentally verified editing site in the coding region that is primate-specific. It would be interesting, therefore, to understand the function of the Alu-containing NARF isoform in the human transcriptome (as it might be responsible for a primate-specific trait); however, as the function of NARF itself is currently not clear, this must await future studies. A Pfam analysis indicates that the Alu-exon is inserted in NARF within a domain defined as 'Iron only hydrogenase large subunit, carboxy-terminal domain', and hence can presumably affect the substrate binding affinity/specificity, or the catalytic activity, of this domain.
###end p 37
###begin p 38
###xml 147 151 147 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
It is worth noting that several other editing targets that cause predicted amino acid changes were detected in a genome-wide search for editing in Alu [13,15], but most of them were located in predicted genes or in aberrantly spliced RNAs. Thus, the actual expression of proteins from these transcripts and the possible functional implications of these sites remain to be verified.
###end p 38
###begin p 39
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 659 665 659 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAR2 </italic>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1025 1027 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 655 658 <span type="species:ncbi:10116">rat</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
Our study provides additional verification for the close relationship between splicing and editing, which was demonstrated when physical association between spliceosomal components and ADAR proteins was reported [41]. The actual mechanism that controls the interconnection of splicing and editing is still largely unknown, but it was shown that additional nuclear machineries are involved, such as the carboxy-terminal domain of RNA polymerase II in the auto-editing of ADAR2 [42,43]. This auto-editing is so far the most studied demonstration of the feedback loop between editing and splicing, where editing-mediated inclusion of an exon fragment in the rat ADAR2 gene changes, in turn, the editing capacitates of the ADAR protein itself [19]. Editing-mediated selection of splice sites has also been observed in other genes [39,44]. ADAR2 knockout mice provide another example of the tight connection between editing and splicing, since the absence of editing in the Q/R site prevents proper splicing of the nearby intron [45]. Our results show that this splicing-editing interconnection can also have evolutionary significance.
###end p 39
###begin p 40
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 83 84 83 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 146 149 146 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 490 503 490 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homo sapiens </italic>
###xml 538 541 538 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 642 646 642 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 714 718 714 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 752 755 752 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 781 785 781 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 490 502 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 567 572 <span type="species:ncbi:9606">human</span>
Although several thousand Alu sequences have the potential to undergo exonization [5], we were able to detect only one reliable event of a coding Alu-exon that seemed to be exonized through RNA editing, indicating that such a combination of evolutionary events is relatively rare in the human genome. However, this evolutionary mechanism for the birth of new exons might recur in other genomes. Moreover, this mechanism might allow additional Alu exonizations in the evolutionary future of Homo sapiens and other primate species. As some Alus are still active in the human genome (at a rate of 1 transposition every 200 births [46]), a novel Alu retroposition in the opposite orientation from a nearby preexisting Alu might lead to dsRNA formation and Alu-exonization even if this Alu does not contain a canonical splice site.
###end p 40
###begin title 41
Conclusion
###end title 41
###begin p 42
###xml 104 108 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 77 82 <span type="species:ncbi:9606">human</span>
We have shown that RNA editing can lead to the creation of a new exon in the human genome. Similarly to Alu retroposition and alternative splicing, RNA editing was not originally 'designed' to serve evolutionary purposes; it was rather recruited for this, probably serendipitously. This demonstrates that the creation of genomic novelty can be assisted by numerous molecular biological mechanisms, most of which were originally designed to function in other processes. The dynamism of our genome can, therefore, arise through surprising paths.
###end p 42
###begin title 43
Materials and methods
###end title 43
###begin title 44
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alus</italic>
Computational search for candidate edited Alus
###end title 44
###begin p 45
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 167 170 167 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 279 282 279 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 418 421 418 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 109 114 <span type="species:ncbi:9606">human</span>
ESTs and cDNAs from GenBank version 136 were aligned to the human genome (version hg16) to identify internal human exons that contain Alu elements, as described in [5]Alu-containing exons were identified using blastn analysis against the Alu consensus with a threshold of 1E-10. Alus having AA/GT or AG/AT 3' ss/5' ss, which flank exons in the protein-coding region of the genes, were taken for further analysis. Only Alu-exons supported by multiple cDNAs and not containing stop codons (in the ESTs and cDNA) were further considered. Exons were manually screened to remove false computational predictions.
###end p 45
###begin title 46
Plasmid construction
###end title 46
###begin p 47
###xml 336 339 336 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 341 344 341 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 55 60 <span type="species:ncbi:9606">human</span>
Oligonucleotide primers were designed to amplify (from human genomic DNA) a minigene that contains exons 7, 8, and 9 (and the introns in between) of NARF (GenBank: ). Each primer contained an additional extension encoding a restriction enzyme sequence. The PCR product of NARF (2.8 kb) was restriction digested and inserted between the KpnI/XhoI sites in the pEGFP-C3 vector, which contains green fluorescent protein (GFP; Clontech, Palo Alto, CA, USA).
###end p 47
###begin title 48
Site directed mutagenesis
###end title 48
###begin p 49
###xml 161 170 161 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PfuTurbo </italic>
###xml 298 301 298 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dpn</italic>
###xml 434 451 427 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 434 450 <span type="species:ncbi:562">Escherichia coli</span>
Overlapping oligonucleotide primers containing the desired mutations were used to amplify a mutation-containing replica of the wild-type minigene plasmid, using PfuTurbo DNA polymerase (Stratagene, La Jolla, CA, USA) (Additional data file 3). After PCR amplification the reaction was digested with DpnI restriction enzyme (New England Biolabs, Ipswich, MA, USA) for 1 h at 37degreesC, 1-3 mul of the reaction was transformed into the Escherichia coli XL-1 strain, and colonies were picked for Mini-prep extraction (Qiagen, Valencia, CA, USA). All plasmids were confirmed by sequencing.
###end p 49
###begin title 50
Transfection, RNA isolation and RT-PCR amplification
###end title 50
###begin p 51
###xml 362 363 356 357 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 155 159 <span type="species:ncbi:9913">calf</span>
###xml 851 877 <span type="species:ncbi:11866">avian myeloblastosis virus</span>
###xml 881 884 <span type="species:ncbi:11866?0.5863095238095238">AMV</span>
293T cells were cultured in Dulbecco's modified Eagle's medium, supplemented with 4.5 g/ml glucose (Biological Industries, Bait-Haemek, Israel), 10% fetal calf serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 1 U/ml nystatin (Biological Industries, Bait-Haemek, Israel). Cells were grown on 6-well plates under standard conditions at 37degreesC with 5% CO2. Cells were grown to 60% confluence, and transfection was performed using FuGENE6 (Roche Diagnostics, Basel, Switzerland) with 1 mug of plasmid DNA. Cells were harvested after 48 h. Total RNA was extracted using TRIzol Reagent (Sigma-Aldrich, St. Louis, MO, USA), followed by treatment with 1 U of RNase-free DNase (Ambion, Austin, TX, USA). Reverse transcription (RT) was preformed on 2 mug total RNA for 1 h at 42degreesC using Oligo-dT reverse primer and 2 U of reverse transcriptase avian myeloblastosis virus (A-AMV; Roche Diagnostics, Basel, Switzerland).
###end p 51
###begin p 52
###xml 506 508 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
The spliced cDNA products derived from the expressed minigenes were detected by PCR using the pEGFP-C3-specific reverse primer and an exon 7 forward primer (Additional data file 3). Amplification was performed for 30 cycles, consisting of 1 minute at 94degreesC, 45 s at 61degreesC, and 1.5 minutes at 72degreesC. The products were resolved on 1.5% agarose gel and confirmed by sequencing. Band quantification was performed by densitometry scanning of ethidium bromide stained gels, using ImageJ software [47].
###end p 52
###begin p 53
For the NMD treatment, cells 48 h post-transfection were subjected to 100 mug/ml puromycin (Sigma-Aldrich, St. Louis, MO, USA) for 4 h before RNA extraction.
###end p 53
###begin title 54
Analysis of RNA editing
###end title 54
###begin p 55
Products from RT-PCR or from PCR obtained from commercial cDNAs (BioChain, Hayward, CA, USA) were separated by electrophoresis on 1.5% agarose gels. The appropriate PCR product was excised and the DNA was extracted and purified (Promega, Madison, WI, USA). Direct sequencing from both ends was done using the ABI PRISM (Applied Biosystems, Foster-City, CA, USA). The editing percentage from direct sequencing was calculated as  for the forward primer and  for the reverse primer; the presented percentages represent an average of three separated experiments or three independent amplifications. The nucleotides were quantified by the Discovery Studio (DS) Gene 1.5 program (Accelrys Inc., San Diego, CA, USA).
###end p 55
###begin title 56
Additional data files
###end title 56
###begin p 57
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 212 215 212 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 304 307 304 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 339 342 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 375 376 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 226 231 <span type="species:ncbi:9606">human</span>
###xml 233 243 <span type="species:ncbi:9598">chimpanzee</span>
###xml 248 262 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 277 291 <span type="species:ncbi:9544">rhesus macaque</span>
The following additional data are available with the online version of this paper. Additional data file 1 contains two figures showing semi-quantitative PCR analysis. Additional data file 2 contains alignment of AluSx between human, chimpanzee and rhesus macaque, and also the rhesus macaque sequence of AluSx and its upstream surrounding AluY sequence. Additional data file 3 is a table listing the primer sequences used in this research.
###end p 57
###begin title 58
Supplementary Material
###end title 58
###begin title 59
Additional data file 1
###end title 59
###begin p 60
Two figures showing semi-quantitative PCR analysis
###end p 60
###begin p 61
Click here for file
###end p 61
###begin title 62
Additional data file 2
###end title 62
###begin p 63
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 135 138 135 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 34 44 <span type="species:ncbi:9598">chimpanzee</span>
###xml 49 63 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 73 87 <span type="species:ncbi:9544">rhesus macaque</span>
Alignment of AluSx between human, chimpanzee and rhesus macaque, and the rhesus macaque sequence of AluSx and its upstream surrounding AluY sequence
###end p 63
###begin p 64
Click here for file
###end p 64
###begin title 65
Additional data file 3
###end title 65
###begin p 66
Primer sequences used in this research
###end p 66
###begin p 67
Click here for file
###end p 67
###begin title 68
Acknowledgements
###end title 68
###begin p 69
We thank Sergey Nemzer for his dedicated assistance. This work was supported by a grant from the Israel Science Foundation (1449/04 and 40/05), MOP Germany-Israel, GIF, DIP, and EURASNET. EE was supported by an Alon Fellowship at Tel Aviv University.
###end p 69
###begin article-title 70
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Initial sequencing and comparative analysis of the mouse genome.
###end article-title 70
###begin article-title 71
Origin and evolution of new exons in rodents.
###end article-title 71
###begin article-title 72
Origin of alternative splicing by tandem exon duplication.
###end article-title 72
###begin article-title 73
On "genomenclature": a comprehensive (and respectful) taxonomy for pseudogenes and other "junk DNA".
###end article-title 73
###begin article-title 74
Is abundant A-to-I RNA editing primate-specific?
###end article-title 74
###begin article-title 75
###xml 39 44 <span type="species:ncbi:9606">human</span>
Initial sequencing and analysis of the human genome.
###end article-title 75
###begin article-title 76
###xml 77 82 <span type="species:ncbi:9606">human</span>
Comparison of multiple vertebrate genomes reveals the birth and evolution of human exons.
###end article-title 76
###begin article-title 77
The birth of an alternatively spliced exon: 3' splice-site selection in Alu exons.
###end article-title 77
###begin article-title 78
Alu-SINE exonization: en route to protein-coding function.
###end article-title 78
###begin article-title 79
An ADAR that edits transcripts encoding ion channel subunits functions as a dimer.
###end article-title 79
###begin article-title 80
###xml 55 60 <span type="species:ncbi:9606">human</span>
Widespread RNA editing of embedded alu elements in the human transcriptome.
###end article-title 80
###begin article-title 81
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
RNA editing level in the mouse is determined by the genomic repeat repertoire.
###end article-title 81
###begin article-title 82
###xml 61 66 <span type="species:ncbi:9606">human</span>
Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome.
###end article-title 82
###begin article-title 83
###xml 27 32 <span type="species:ncbi:9606">human</span>
A survey of RNA editing in human brain.
###end article-title 83
###begin article-title 84
###xml 66 71 <span type="species:ncbi:9606">human</span>
Systematic identification of abundant A-to-I editing sites in the human transcriptome.
###end article-title 84
###begin article-title 85
Small regulatory RNAs in mammals.
###end article-title 85
###begin article-title 86
Regulating gene expression through RNA nuclear retention.
###end article-title 86
###begin article-title 87
###xml 39 44 <span type="species:ncbi:9606">human</span>
SINEs point to abundant editing in the human genome.
###end article-title 87
###begin article-title 88
Regulation of alternative splicing by RNA editing.
###end article-title 88
###begin article-title 89
Prenylated prelamin A interacts with Narf, a novel nuclear protein.
###end article-title 89
###begin article-title 90
RNA editing by adenosine deaminases that act on RNA.
###end article-title 90
###begin article-title 91
The many roles of an RNA editor.
###end article-title 91
###begin article-title 92
###xml 53 76 53 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans </italic>
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 53 75 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
RNA hairpins in noncoding regions of human brain and Caenorhabditis elegans mRNA are edited by adenosine deaminases that act on RNA.
###end article-title 92
###begin article-title 93
Inosine exists in mRNA at tissue-specific levels and is most abundant in brain mRNA.
###end article-title 93
###begin article-title 94
Single Nucleotide Polymorphism
###end article-title 94
###begin article-title 95
Identification of RNA editing sites in the SNP database.
###end article-title 95
###begin article-title 96
RNA editing in brain controls a determinant of ion flow in glutamate-gated channels.
###end article-title 96
###begin article-title 97
Comparative analysis identifies exonic splicing regulatory sequences - the complex definition of enhancers and silencers.
###end article-title 97
###begin article-title 98
ESRsearch Tool
###end article-title 98
###begin article-title 99
RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons.
###end article-title 99
###begin article-title 100
ESEfinder: A web resource to identify exonic splicing enhancers.
###end article-title 100
###begin article-title 101
###xml 70 75 <span type="species:ncbi:9606">human</span>
Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases.
###end article-title 101
###begin article-title 102
###xml 13 18 <span type="species:ncbi:9606">human</span>
Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette.
###end article-title 102
###begin article-title 103
Regulation of serotonin-2C receptor G-protein coupling by RNA editing.
###end article-title 103
###begin article-title 104
Nervous system targets of RNA editing identified by comparative genomics.
###end article-title 104
###begin article-title 105
###xml 99 103 <span type="species:ncbi:10090">mice</span>
Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice.
###end article-title 105
###begin article-title 106
Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims.
###end article-title 106
###begin article-title 107
Glutamate receptors: RNA editing and death of motor neurons.
###end article-title 107
###begin article-title 108
Underediting of glutamate receptor GluR-B mRNA in malignant gliomas.
###end article-title 108
###begin article-title 109
A bioinformatic screen for novel A-I RNA editing sites reveals recoding editing in BC10.
###end article-title 109
###begin article-title 110
RNA editing activity is associated with splicing factors in lnRNP particles: The nuclear pre-mRNA processing machinery.
###end article-title 110
###begin article-title 111
RNA editing and alternative splicing: the importance of co-transcriptional coordination.
###end article-title 111
###begin article-title 112
An editor controlled by transcription.
###end article-title 112
###begin article-title 113
###xml 24 35 24 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 24 34 <span type="species:ncbi:7227">Drosophila</span>
Editing efficiency of a Drosophila gene correlates with a distant splice site selection.
###end article-title 113
###begin article-title 114
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2.
###end article-title 114
###begin article-title 115
Mammalian retroelements.
###end article-title 115
###begin article-title 116
ImageJ
###end article-title 116
###begin title 117
Figures and Tables
###end title 117
###begin p 118
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 124 128 124 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 174 179 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NARF </italic>
###xml 223 226 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 246 249 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 375 378 375 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 423 426 423 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 448 451 448 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 671 674 671 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 795 799 795 799 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 849 853 849 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 979 983 979 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 105 110 <span type="species:ncbi:9606">human</span>
The birth of an Alu-exon through RNA editing. Editing prediction was inferred from alignment of cDNAs to human genomic DNA. (a) Schematic illustration of exons 7 to 9 of the NARF gene. Exons are depicted as blue boxes; the Alu-exon, derived from AluSx (AEx; purple box), is in a sense orientation and is shown in the middle. The intronic, antisense-orientation Alu sequence (AluS) is 25 base-pairs upstream of the exonized Alu. Sense and antisense Alus are expected to create a dsRNA secondary structure, thus allowing RNA editing. RNA editing changes an AA dinucleotide into a functional AG 3' splice site (lower panel). RNA editing also occurs in five positions in the Alu-exon itself (E1, E2, E3, E4 and E5). In the first position (E1), editing changes a UAG stop codon into a UGG Trp codon. (b) Predicted folding between the sense and antisense Alu sequences (upper and lower lines, respectively). Adenosines that undergo editing are marked by red. Splice sites utilized for Alu exonization are marked as 5' ss and 3' ss on the alignment.
###end p 118
###begin p 119
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NARF </italic>
###xml 80 84 80 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 310 313 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 400 403 400 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 625 629 625 629 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 110 115 <span type="species:ncbi:9606">human</span>
Levels of Alu-exon inclusion and RNA editing in the endogenous human NARF gene. (a) cDNAs from various normal human tissues or cDNAs from various cell-lines were PCR amplified using primers specific for the two exons flanking the exonized Alu (upper and lower panels, respectively). The inclusion level of the Alu-exon is indicated at the top of the panel, and represents the total percentage of the Alu-containing mRNA isoform, where 100% corresponds to the total of both mRNA isoforms (inferred by the ImageJ program). Each PCR product was confirmed by sequencing. Schemata of the two mRNA products are shown on the right. (b) Editing efficiency in the five exonic sites (E1, E2, E3, E4 and E5; see Figure 1 for site positions) in different tissues and cell lines. The editing frequencies in each of the five edited sites, derived from sequence results obtained from an average of three independent amplifications, were quantified using the Discovery Studio Gene 1.5 program.
###end p 119
###begin p 120
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 48 52 48 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NARF </italic>
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NARF </italic>
###xml 230 234 230 234 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 516 519 516 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 680 683 674 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 727 730 721 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 822 825 816 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 150 155 <span type="species:ncbi:9606">human</span>
###xml 266 271 <span type="species:ncbi:9606">human</span>
The antisense Alu is essential for exonization. (a) An illustration of the NARF minigene that was constructed, containing the genomic sequence of the human NARF gene from exon 7 to 9. The sites that were mutated in (b) are shown. (b) The minigene was transfected to human 293T cells, and total RNA was collected and examined by RT-PCR analysis using specific primers to mRNA products of the plasmid minigene. The first lane is the wild-type (WT) pattern. Lanes 2 and 3 represent a deletion of the antisense intronic Alu. Lane 3 also represents an AA-->AG mutation at the 3'ss. Lanes 4 and 5 represent an AA-->AT and AA-->AG mutation at the 3'ss (without deletion of the antisense Alu), respectively. The inclusion level of the Alu-exon is indicated at the top of the gel, and represents the total percentage of the edited-Alu-containing mRNA isoform, where 100% corresponds to the total of both mRNA isoforms (inferred using the ImageJ program). Schemata of the two mRNA products are shown on the right.
###end p 120
###begin p 121
###xml 79 83 79 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 146 149 146 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 156 159 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AEx</italic>
###xml 188 191 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 194 197 194 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 283 287 283 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 354 358 354 358 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 383 386 383 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 635 638 635 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 754 758 754 758 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
Editing is directed by a specific sequence surrounding the editing nucleotide. (a) An illustration showing the positions that were mutated in the Alu-exon (AEx) and the antisense intronic AluS (AluS): the flanking nucleotides of the edited E1 site, and the position in the antisense Alu that is predicted to be opposite to the E1 in the dsRNA formation. (b) Chromas sequences of the Alu-exon editing of the wild-type (WT) and three mutants from (a). WT and mutant plasmids were introduced into 293T cells by transfection, total RNA was extracted, and splicing products were separated on 1.5% agarose gel following RT-PCR analysis. The Alu-exon inclusion of the WT and mutants is highly similar (not shown). The edited positions are highlighted in black. (c) Rounded editing frequencies of each of the five edited sites, from three separate experiments, were quantified using the Discovery Studio Gene 1.5 program.
###end p 121
###begin p 122
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
The effect of editing in exonic sites on exon inclusion levels. Lane 1 represents a deletion of the Alu antisense and also a mutation that creates an AG at the 3'ss. This plasmid was used to generate an A-to-G mutation in each of the exonic edited sites (lanes 2-6). This is a similar analysis to that shown in Figure 3.
###end p 122
###begin p 123
Exonic regulatory sequences predicted to be changed following editing in the five exonic sites
###end p 123
###begin p 124
###xml 280 283 280 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 358 364 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224;</sup>
###xml 393 406 388 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8225;</sup>
###xml 425 430 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 438 450 421 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#167;</sup>
###xml 504 518 476 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#182;</sup>
###xml 547 550 506 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#165;</sup>
The sequence of the exonic splicing regulatory sequence is shown. The edited 'A' nucleotide is in bold (unless otherwise indicated). The numbers in parentheses indicate the binding score before/after editing; NA indicates no available score. *Edited sites: E1, position 19 in the Alu-exon; E2, position 24; E3, position 32; E4, position 33; E5, position 46. daggerPredicted by ESEfinder [31]. double daggerPredicted by Goren et al. [28]. section signThis unedited ESR overlaps with both E1 and E2 sites. paragraph signPredicted by RESCU-ESE [30]. yenSites E1 and E5 created two different hexamers for the edited and unedited position, according to RESCU-ESE [30].
###end p 124

